Kairos Pharma, LTD. (KAPA) (CIK 0001962011) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001493152-26-002996
- Form
- CORRESP
- Filer
- Kairos Pharma, LTD. (KAPA) (CIK 0001962011)
- CIK
- 0001962011
- Ticker
- KAPA
- Filed
- 2026-01-21
- SIC industry
- 2834
- HQ
- Los Angeles, CA
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1962011/000149315226002996/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗
Other comment-letter activity for this filer